Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 4 1Phase 2 1

Status

Completed 5Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 7Observational 5

Sponsor

Cancer Type

Breast 37Lymphoid 36CNS 15Genitourinary 7Gastrointestinal 5Other hematologic neoplasm 3Gynecologic 2Thoracic 1Other 1Dermatologic 1

Conditions

Prostatic Neoplasms 5016Carcinoma, Renal Cell 1574Urinary Bladder Neoplasms 1279Kidney Neoplasms 723Breast Neoplasms 642Neoplasms 628Carcinoma, Transitional Cell 487Neoplasm Metastasis 468Carcinoma, Non-Small-Cell Lung 467Melanoma 421Ovarian Neoplasms 399Colorectal Neoplasms 370Lung Neoplasms 333Pancreatic Neoplasms 262Sarcoma 231Stomach Neoplasms 226Uterine Cervical Neoplasms 223Testicular Neoplasms 215Non-Muscle Invasive Bladder Neoplasms 214Head and Neck Neoplasms 192Squamous Cell Carcinoma of Head and Neck 187Colonic Neoplasms 167Carcinoma, Hepatocellular 165Esophageal Neoplasms 164Endometrial Neoplasms 164Wilms Tumor 159Recurrence 131Triple Negative Breast Neoplasms 128Neuroblastoma 127Small Cell Lung Carcinoma 125

Interventions

enzalutamide 1beta Carotene 1Vitamin E 1Prednisone 1Gonadotropin-Releasing Hormone 1Geritol 1Behavior Therapy 1Ascorbic Acid 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Interventional × Cognitive Dysfunction × Genitourinary × Clear all
NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Northwestern University

Phase 4 Active not recruiting
100 enrolled
Genitourinary

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

NCT05582759 2024-05-17

SHERE-Relief 2

University of Kansas Medical Center

Phase NA Completed
45 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms, Parasomnias, Cognitive Dysfunction

NCT02907372 2023-01-11

COG-PRO

Centre Francois Baclesse

Phase NA Completed
163 enrolled
Genitourinary

Prostatic Neoplasms, Cognitive Dysfunction

NCT01691976 2020-11-20

Mild Cognitive Impairment in Men Following Androgen Deprivation

Imperial College London

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms, Cognitive Dysfunction

NCT03191968 2019-12-20

BOOST

University of Illinois at Urbana-Champaign

Phase 2 Completed
27 enrolled
Genitourinary

Motor Activity, Prostatic Neoplasms, Cognitive Dysfunction

NCT03285048 2018-10-22

CaCRT

Yale University

Phase NA Completed
12 enrolled
Genitourinary

Neoplasms, Prostatic Neoplasms, Cognitive Dysfunction

NCT00270647 2018-02-28

PHS II

Brigham and Women's Hospital

Phase NA Completed
14,641 enrolled
GastrointestinalGenitourinary

Cardiovascular Diseases, Eye Diseases, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡